Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03713320
Title SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides (SOLAR)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors miRagen Therapeutics, Inc.
Indications

mycosis fungoides

Therapies

Vorinostat

MRG-106

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | CAN | BEL


No variant requirements are available.